Urine Drug Screening Requirement

L3 decorative image

The University of Pittsburgh School of Nursing is aware of the confusion surrounding mandatory clinical requirements for students with our clinical partners, Allegheny Health Network (AHN) and UPMC.

Effective the Fall 2023 term, students must submit a urine drug screening before the start of their clinical term.

Students assigned to clinicals at a UPMC facility are now required to undergo a 5-panel drug test (amphetamines, cocaine, marijuana, opiates, and PCP), while students assigned to clinicals at an AHN facility will now undergo a 9-panel drug test (cocaine, opiates, amphetamine, phencyclidine, barbiturates, oxycodone, benzodiazepines, methamphetamine, and methadone).

Students are responsible for the cost of their drug tests. These requirements are mandatory and were established by each medical facility. If a urine drug test yields positive results, the clinical agency will conduct a further evaluation.

For more information, please refer to the frequently asked questions (FAQ) below. Any additional questions may be directed to Erin Hrizo, Clinical Placement Specialist, by email elh175@pitt.edu or by phone at 412-624-6616.